#None #Seraphina Therapeutics #fatty15 #Dr. Eric Venn-Watson

Seraphina Therapeutics Achieves Incredible Growth in 2025

On August 12, 2025, Inc. announced its annual list of the 5000 fastest-growing private companies in America, and to the surprise of many, Seraphina Therapeutics ranked No. 177. This is a significant achievement for the company, which saw an astonishing 3,031% revenue growth over three years. This growth trajectory marks its entry into an exclusive club, joining the ranks of other renowned companies like Microsoft, Chobani, and Under Armour.

Seraphina Therapeutics, co-founded by Dr. Eric Venn-Watson and his wife Stephanie, has made waves in the health and wellness industry with its groundbreaking product, fatty15. This longevity supplement, backed by substantial scientific research, has been a game-changer. Dr. Venn-Watson commented on the company's mission, stating, "We aim to improve people’s lives meaningfully in just a matter of months."

The rise of Seraphina was not merely a stroke of luck; it was the result of meticulous strategy and dedication. Following its launch in January 2021, fatty15 quickly gained traction among consumers. The product, which boasts a 95% monthly customer retention rate, has managed to attract over 100,000 active subscribers, a testament to its effectiveness and popularity.

In a landscape characterized by economic uncertainty, inflation, and evolving market dynamics, Seraphina’s journey has been symbolic of resilience. This year's Inc. 5000 honorees collectively reflected the spirit of entrepreneurial tenacity, with a median three-year revenue growth rate of 1,552% and the creation of nearly 49,000 jobs across the United States.

The company’s performance can be attributed not only to product excellence but also to innovative channels of distribution. Seraphina has successfully penetrated markets both through direct-to-consumer sales and expansion into platforms like Amazon, ensuring broader accessibility for its groundbreaking supplements.

A spokesperson for Inc. praised the honorees this year, stating, "Earning a spot in the Inc. 5000 reflects a company's clarity of vision and determination. These businesses have not only withstood challenges; they have thrived against them, reminding us that the entrepreneurial spirit fuels the U.S. economy."

Later this year, Seraphina will be celebrated for its achievements at the 2025 Inc. 5000 Conference and Gala in Phoenix, scheduled for October 22-24. The event will honor the top 500 companies, whose profiles will feature in the Fall issue of Inc. magazine.

The methodology utilized for determining the Inc. 5000 rankings involved analyzing revenue growth from 2021 to 2024. Companies had to meet specific criteria, including a minimum revenue threshold and the requirement to be U.S.-based and privately held.

In closing, Seraphina Therapeutics is setting a remarkable precedent in the health and wellness industry. With consumer-centric products and a focus on scientific advancement, the company not only stands out in the Inc. 5000 list but also in the hearts of its dedicated customers. As the company continues to grow, its impact on global health initiatives and innovations in longevity supplements looks promising. Let's keep an eye on Seraphina Therapeutics and its inspiring journey ahead.